Takeda signed a collaboration worth up to $600 million with Insilico Medicine on July 3, 2026, tapping the company's generative AI drug-discovery platform to find new molecules—part of a $7 billion deal-making sprint that has investors excited and skeptics waiting for actual approvals.
Mercy hospitals in Missouri and Arkansas are piloting an ambient AI tool built into Microsoft Dragon Copilot that documents nursing care by listening in—one nurse says it gave her two hours back in a single shift.
A new UPMC and KLAS Research survey finds 93% of health systems have deployed third-party AI, but only 44% have a dedicated environment to test it—exposing a widening gap between adoption and governance.
Kintsugi Voice analyzes subtle acoustic patterns in short speech samples to screen for depression, part of a growing body of research into vocal biomarkers for mental health.
Sweden's 105,000-woman MASAI trial found AI-supported mammography reduced aggressive interval cancers, while a $16 million U.S. trial called PRISM now tests the same question nationwide.
AI-Stroke's smartphone screening tool detected twice as many true stroke cases as standard paramedic checklists in a study of 2,000 emergency staff.
Pennsylvania's lawsuit against Character.AI over chatbots posing as licensed medical professionals could reshape how AI companion apps are allowed to talk about health.
The FDA's list of authorized AI medical devices topped 1,357 entries in January 2026, and 77 percent of them are radiology tools—revealing both AI's biggest healthcare win and its biggest gaps.
A Swedish AI model that predicts molecular behavior in a fraction of the usual computing time could compress the costliest early stage of drug discovery.
Advocate Health's AI imaging rollout across 22 sites in Wisconsin and North Carolina has expanded from spotting pulmonary embolisms to catching rib fractures, aortic dissections, and brain aneurysms.